0001615774-14-000031.txt : 20140813 0001615774-14-000031.hdr.sgml : 20140813 20140813170724 ACCESSION NUMBER: 0001615774-14-000031 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140813 DATE AS OF CHANGE: 20140813 EFFECTIVENESS DATE: 20140813 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Enumeral Biomedical Holdings, Inc. CENTRAL INDEX KEY: 0001561551 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] IRS NUMBER: 990376434 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-222874 FILM NUMBER: 141038372 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQUARE, STREET 2: BUILDING 400, 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: (617) 674-1865 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE, STREET 2: BUILDING 400, 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: CERULEAN GROUP, INC. DATE OF NAME CHANGE: 20121102 D 1 primary_doc.xml X0707 D LIVE 0001561551 Enumeral Biomedical Holdings, Inc. ONE KENDALL SQUARE BUILDING 400, 4TH FLOOR CAMBRIDGE MA MASSACHUSETTS 02139 (617) 674-1865 DELAWARE Cerulean Group, Inc. CERULEAN GROUP, INC. Corporation true 2012 Arthur H. Tinkelenberg One Kendall Square Building 400, 4th Floor Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Chief Executive Officer, President and Director John J. Rydzewski One Kendall Square Building 400, 4th Floor Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Executive Chairman Derek Brand One Kendall Square Building 400, 4th Floor Cambridge MA MASSACHUSETTS 02139 Executive Officer Vice President of Business Development and Secretary Anhco Nguyen One Kendall Square Building 400, 4th Floor Cambridge MA MASSACHUSETTS 02139 Executive Officer Vice President of Research and Development Kevin Sarney One Kendall Square Building 400, 4th Floor Cambridge MA MASSACHUSETTS 02139 Executive Officer Vice President of Finance, Chief Accounting Officer and Treasurer Daniel B. Wolfe One Kendall Square Building 400, 4th Floor Cambridge MA MASSACHUSETTS 02139 Director Allan Rothstein One Kendall Square Building 400, 4th Floor Cambridge MA MASSACHUSETTS 02139 Director Barry Buckland One Kendall Square Building 400, 4th Floor Cambridge MA MASSACHUSETTS 02139 Director Pharmaceuticals Decline to Disclose 06b false 2014-07-31 false true true true Units consisting of common stock and warrants to purchase common stock true The Issuer entered into a definitive merger agreement with Enumeral Biomedical Corp. and Enumeral Acquisition Corp., dated as of July 31, 2014. 100000 EDI Financial, Inc. 15699 None None 1431 GREENWAY DRIVE SUITE 330 IRVING TX TEXAS 75038 All States false Katalyst Securities LLC 112494 None None 15 MAIDEN LANE, ROOM 601 NEW YORK NY NEW YORK 10038 AZ ARIZONA CA CALIFORNIA FL FLORIDA IL ILLINOIS IN INDIANA MA MASSACHUSETTS MN MINNESOTA NJ NEW JERSEY NY NEW YORK OH OHIO PA PENNSYLVANIA TX TEXAS VA VIRGINIA WA WASHINGTON false 21549510 21549510 0 false 253 2154951 0 Cash commission of an aggregate of 10% of the gross proceeds raised from investors in the PPO was paid to two placement agents. The placement agents also received five-year warrants to purchase an aggregate of 10% of the number of shares sold in the PPO. 2600000 true Certain proceeds will be used by the Company for general working capital, including compensation expected to be paid to certain executive officers and/or directors who are listed as Related Persons herein over a 24 month period. false Enumeral Biomedical Holdings, Inc. /s/ Arthur Tinkelenberg Arthur Tinkelenberg Chief Executive Officer 2014-08-12